Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia, Myeloid, Acute 13Leukemia 5Recurrence 4Myelodysplastic Syndromes 2Solid Tumors 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid 1Leukemia, Erythroblastic, Acute 1Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies 1Aortic aneurysm, familial thoracic 4 1

Interventions

fludarabine phosphate 38Cyclophosphamide 37Peripheral Blood Stem Cell Transplantation 32Busulfan 28Tacrolimus 26Whole-Body Irradiation 20Mycophenolic Acid 19Methotrexate 17Antilymphocyte Serum 17ruxolitinib 16fludarabine 14Filgrastim 13Cyclosporine 12Melphalan 11Radiotherapy 9Etoposide 9thymoglobulin 8Psychiatric Rehabilitation 8Prednisone 8Methylprednisolone 8Cytarabine 6Cord Blood Stem Cell Transplantation 6Thiotepa 5Sirolimus 5Imatinib Mesylate 5Flow Cytometry 5Azacitidine 5Alemtuzumab 5sargramostim 4merphos 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Primary Myelofibrosis × quizartinib × Clear all
NCT00462761 2020-05-11

A Phase I Study of AC220 in Patients With Relapsed/Refractory Acute Myeloid Leukemia Regardless of FLT3 Status

Daiichi Sankyo

Phase 1 Completed
76 enrolled 12 charts
MyeloidOther hematologic neoplasm

Aortic aneurysm, familial thoracic 4, Leukemia, Erythroblastic, Acute, Leukemia, Myelodysplastic Syndromes, Recurrence, Leukemia, Myeloid, Acute, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡